Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1982
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: The study was performed by an experienced laboratory using an accepted methodology that included the typical Salmonella strains plus E. coli, both with and without metabolic activation.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1982

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
other: Japanese Industrial Safety and Health Law, 1979,
Qualifier:
equivalent or similar to guideline
Guideline:
JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
GLP compliance:
not specified
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
N,N'-ethylenebis(3,4,5,6-tetrabromophthalimide)
EC Number:
251-118-6
EC Name:
N,N'-ethylenebis(3,4,5,6-tetrabromophthalimide)
Cas Number:
32588-76-4
Molecular formula:
C18H4Br8N2O4
IUPAC Name:
N,N'-ethylenebis(3,4,5,6-tetrabromophthalimide)
Test material form:
other: Pale yellow powder

Method

Target gene:
Typical for the bacterial strains tested.
Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Additional strain / cell type characteristics:
other: tryptophan-deficient E.coli WP2 uvrA
Metabolic activation:
with and without
Metabolic activation system:
Rat liver S9
Test concentrations with justification for top dose:
10, 50, 100, 500, 1000, 5000 ug/plate; duplicate plates/dose, bacterial strain, and activation
Vehicle / solvent:
DMSO
Controls
Untreated negative controls:
not specified
Negative solvent / vehicle controls:
yes
Remarks:
DMSO
True negative controls:
not specified
Positive controls:
yes
Remarks:
2 -(2 -furyl)-3 -(5 -nitro-2 -furyl)acrylamide, N-ethyl-N'nitro-N-nitrosoguanidine, 9 -Aminoacridine, 2 -nitrofluorene, 2 -aminoanthracene

Results and discussion

Test resultsopen allclose all
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

See attached document for table of results.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative

EBTBP was not mutagenic to 5 strains of Salmonella typhimurium and E. coli WP2 uvrA when tested with and without S9 metabolic activation.
Executive summary:

In the Ames assay, the tester strains used wereSalmonellaTA98, TA100, TA1535, TA1537, and TA1538 andE. coli, WP2 uvrA. Each strain was tested with and without a source of exogenous metabolic activation of Arochlor-induced rat liver microsomes. EBTBP dose levels were 0, 1, 10, 100, 500, 1,000 and 5,000 ug/plate. Positive and negative controls were included, and performed as expected. No increase in revertant colonies was found at any EBTBP dose level either in the presence or absence of microsomal enzymes. EBTBP was not genetically active in this assay.